Gem Pharmaceuticals, LLC (GEM)

Oncology Corporate Profile

HQ Location

941 Lake Forest Circle
Birmingham, AL 35244

Company Description

Gem Pharmaceuticals is a clinical-stage biopharmaceutical company developing proprietary anthracycline derivatives specifically designed to eliminate the critical cardiotoxicity side effect of this powerful class of chemotherapeutics while maintaining their well-documented anti-cancer efficacy.

Website: http://www.gempharmaceuticals.com/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
GPX-150anthracycline compoundVarious cancer typesI

View additional information on product candidates here »

Source: http://www.gempharmaceuticals.com/

Recent News Headlines

8/21/2017 06:19 am

8/21/2017 06:19 am

8/21/2017 06:19 am

8/21/2017 06:19 am

5/2/2017 06:18 am

5/2/2017 06:18 am

4/20/2017 12:18 pm

4/20/2017 12:18 pm

4/9/2017 12:17 pm

Results - Singapore Rough Ruby Auction

12/19/2016 07:01 am

[at noodls] - Gemfields plc ('Gemfields' or 'the Company') 19 December 2016 Gemfields plc (AIM: GEM) is pleased to announce the results of its auction of rough ruby extracted by Montepuez Ruby Mining Limitada (which ...

Update to December 2016 Emerald Auction

12/1/2016 03:02 pm

[at noodls] - Gemfields plc ('Gemfields' or the 'Company') 1 December 2016 Gemfields plc (AIM: GEM) announces that its auction of predominantly higher quality emeralds from the Kagem emerald mine in Zambia, originally ...

Change in registered office address

12/1/2016 03:02 pm

[at noodls] - Gemfields plc ('Gemfields' or the 'Company') 30 November 2016 Gemfields plc (AIM: GEM) announces that the Company's registered office address has changed from 23 King Street, London, SW1Y 6QY to 1 New ...

Result of AGM

11/30/2016 05:03 am

[at noodls] - Gemfields plc ('Gemfields' or the 'Company') 24 November 2016 Gemfields plc (AIM: GEM) is pleased to announce that at the Annual General Meeting ('AGM') of the Company held today, all resolutions were ...

Grant of Share Options

11/10/2016 05:05 pm

[at noodls] - Gemfields plc ('Gemfields' or the 'Company') 10 November 2016 Gemfields (AIM: GEM) announces that it has granted to certain directors and employees a total of 6,715,000 options over ordinary shares of ...

Board changes

11/1/2016 12:01 pm

[at noodls] - Gemfields plc ('Gemfields' or the 'Company') 1 November 2016 Gemfields plc (AIM: GEM) is pleased to announce that, further to the announcement of 18 October 2016, the Company has appointed Janet Boyce ...

Market Update - Quarter to 30 September 2016

11/1/2016 07:01 am

[at noodls] - Gemfields plc ('Gemfields' or the 'Company') 1 November 2016 Gemfields plc (AIM: GEM) is pleased to present an operational update for the three month period ending 30 September 2016, the first quarter ...

Notice of 2016 Annual General Meeting

10/28/2016 06:00 am

[at noodls] - Gemfields plc ('Gemfields' or the 'Company') 28 October 2016 Gemfields plc (AIM: GEM) announces that the Company's Annual General Meeting will be held at 11.00 a.m. (GMT) on Thursday, 24 November 2016 ...

Changes to Board of Directors

10/18/2016 02:05 pm

[at noodls] - Gemfields plc ('Gemfields' or 'the Company') 18 October 2016 Gemfields plc announces the resignation of COO, Devidas Shetty, who will leave the Gemfields Group and step down from the board of directors ...

Capital Markets Day

10/13/2016 06:01 am

[at noodls] - Gemfields plc ('Gemfields' or the 'Company') 13 October 2016 Gemfields plc (AIM: GEM), the leading supplier of responsibly sourced coloured gemstones, is holding its first for analysts and institutional ...

QOPI Participation Leads to Improved Assessment and Management of Opioid-Associated Constipation

10/5/2016 04:25 pm

(ASCO in Action) Oct 4, 2016 - A new article in the Journal of Oncology Practice (JOP) used data from ASCO’s Quality Oncology Practice Initiative (QOPI®) to improve assessment and management of opioid-associated constipation (OAC).

Final audited results for the year to 30 June 2016

9/26/2016 06:00 am

[at noodls] - Gemfields plc ('Gemfields' or the 'Company' or the 'Group') (AIM: GEM) Final audited results for the year ended 30 June 2016 26 September 2016 Financial Highlights · Revenue of US$193.1 million (2015: ...

Navigating Cancer Unveils Patient Relationship Management Platform

9/15/2016 05:06 pm

(TheStreet) Sept 15, 2016 - New platform is the most comprehensive patient-centered operating system available for oncology clinics.

Notice of Final Results

9/13/2016 06:00 am

[at noodls] - Gemfields plc ('Gemfields' or the 'Company') 13 September 2016 Gemfields plc (AIM: GEM), the leading supplier of responsibly sourced coloured gemstones, will be reporting its final results for the year ...